药用甘油市场规模、份额及成长分析（按类型、原料、应用及地区划分）－2026-2033年产业预测

2024 年全球药用甘油市场规模为 4,108 万美元，预计从 2025 年的 4,383 万美元成长到 2033 年的 7,364 万美元，预计在预测期（2026-2033 年）内将以 6.7% 的复合年增长率成长。

全球药用甘油市场正蓬勃发展，这主要得益于其安全性和多功能性，使其广泛应用于胶囊、糖浆和外用製剂等药物配方中。尤其是在新兴市场，对止咳糖浆、创伤护理软膏和甘油胶囊的需求不断增长，推动了甘油的消费。製药业的成长，特别是亚太和拉丁美洲地区的成长，以及能够生产高纯度产品的製造技术的进步，都进一步促进了这一趋势。向植物来源甘油的转变符合对永续生物基原料的需求。然而，原材料供应波动、与药用级认证相关的生产成本以及供应链中断等挑战可能会影响定价策略和市场动态，尤其对中小型製造商而言。

推动全球药用甘油市场发展的因素

全球药用甘油市场正经历显着成长，这主要得益于其在各种药物製剂（包括糖浆、胶囊、软膏和给药系统）中的广泛应用。这项需求激增主要由製药业的扩张所驱动，尤其是在医疗保健技术快速发展的新兴国家。此外，生物製药生产的日益重视以及向创新复杂药物製剂的转变，预计将进一步推动对高品质药用甘油的需求。甘油的安全性、稳定性和保湿特性使其成为不断发展的製药行业中不可或缺的成分。

限制全球药用甘油市场的因素

全球药用甘油市场面临许多挑战，主要原因是其高度依赖棕榈油和大豆油等原料，极易受到市场波动的影响。气候变迁、贸易限制以及生质柴油产业的波动等因素都会对甘油的供应和价格产生重大影响。这些波动会扰乱供应链，使中小生产商，尤其是那些专注于药用辅料的生产商，难以维持生产计划并确保盈利。这可能导致市场不稳定，进而影响整个产业的成长和竞争力。

全球药用甘油市场趋势

全球药用甘油市场正经历着向植物来源甘油的显着转变，这主要受消费者对永续性和纯素替代品的需求日益增长的推动。这一市场趋势的特点是，消费者越来越倾向于选择符合道德规范、洁净标示的产品，这些产品需要满足更高的透明度和环境责任标准。随着製药公司积极响应消费者压力和监管要求，从传统的动物性成分向植物来源甘油的过渡正在加速，尤其是在欧洲和北美等地区。这项变化不仅反映了消费者偏好的转变，也标誌着製药业对永续实践的更广泛承诺。

目录

介绍

• 调查目标
• 市场定义和范围

调查方法

• 调查过程
• 二手资料和一手资料方法
• 市场规模估算方法

执行摘要

• 全球市场展望
• 市场主要亮点
• 细分市场概览
• 竞争格局概述

市场动态与展望

• 总体经济指标
• 驱动因素和机会
• 限制与挑战
• 供给面趋势
• 需求面趋势
• 波特的分析和影响

关键市场考察

• 关键成功因素
• 影响市场的因素
• 关键投资机会
• 生态系测绘
• 市场吸引力指数（2025）
• PESTEL 分析
• 价值链分析
• 定价分析
• 案例研究
• 监管环境
• 技术评估

全球药用甘油市场规模（按类型及复合年增长率划分）（2026-2033 年）

• 纯度99.7%
• 纯度99.7%或更高

全球药用甘油市场规模（按来源和复合年增长率划分）（2026-2033 年）

• 动物源性
• 植物来源

全球药用甘油市场规模（按应用领域及复合年增长率划分）（2026-2033 年）

• 口服
• 外用

全球药用甘油市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• IOI Oleo GmbH（Germany）
• Archer Daniels Midland Company（ADM）（United States）
• KLK Oleo（Malaysia）
• Oleon NV（Belgium）
• Dow, Inc.（United States）
• Cargill, Incorporated（United States）
• Emery Oleochemicals（Malaysia）
• P&G Chemicals（United States）
• Wilmar International Limited（Singapore）
• The Chemical Company（TCC）（United States）
• Godrej Industries Limited（India）
• Twin Rivers Technologies, Inc.（United States）
• VVF LLC（India）
• Avril Group（France）
• GLACONCHEMIE GmbH（Germany）
• Croda International Plc（United Kingdom）
• Rajaram Solvents Pvt. Ltd.（India）
• 3F Chimica SpA（Italy）
• Solvay SA（Belgium）
• Peter Greven GmbH & Co. KG（Germany）

结论与建议

Global Pharmaceutical Glycerine Market size was valued at USD 41.08 Million in 2024 and is poised to grow from USD 43.83 Million in 2025 to USD 73.64 Million by 2033, growing at a CAGR of 6.7% during the forecast period (2026-2033).

The global pharmaceutical glycerine market is on an upward trajectory, driven by its applications in drug formulations, including capsules, syrups, and topical products, owing to its safety and versatility. Increasing demand for cough syrups, wound care ointments, and glycerine-based capsules, particularly in emerging markets, is boosting glycerine consumption. Growth in the pharmaceutical sector, especially in Asia-Pacific and Latin America, coupled with advancements in manufacturing yielding higher purity products, accelerates this trend. The shift towards plant-derived glycerine aligns with the demand for sustainable, bio-based raw materials. However, challenges such as raw material supply fluctuations, production costs associated with pharmaceutical-grade certification, and disruptions in supply chains can impact pricing strategies and market dynamics, particularly for smaller manufacturers.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharmaceutical Glycerine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pharmaceutical Glycerine Market Segments Analysis

Global Pharmaceutical Glycerine Market is segmented by Type, Source, Application and region. Based on Type, the market is segmented into 99.7% Purity and Above 99.7% Purity. Based on Source, the market is segmented into Animal and Plant. Based on Application, the market is segmented into Oral Use and External use. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pharmaceutical Glycerine Market

The global pharmaceutical glycerine market is experiencing significant growth driven by its diverse applications in various drug formulations, including syrups, capsules, ointments, and drug delivery systems. This surge in demand is primarily attributed to the expanding pharmaceutical sector, particularly in emerging economies, where healthcare advancements are on the rise. Furthermore, the growing focus on biopharmaceutical production and the shift towards innovative and complex drug formulations are expected to further boost the need for premium pharmaceutical glycerine. Its attributes, such as safety, stability, and moisture retention, make glycerine an essential ingredient in this evolving landscape of pharmaceuticals.

Restraints in the Global Pharmaceutical Glycerine Market

The Global Pharmaceutical Glycerine market faces notable challenges due to its dependence on raw materials such as palm and soybean oils, which can experience market volatility. Factors such as climate change, trade limitations, and variations in the biodiesel sector can significantly impact the availability and pricing of glycerine. These fluctuations may lead to supply chain disruptions, making it difficult for manufacturers to maintain production schedules and profitability, particularly for smaller companies specializing in pharmaceutical excipients. Consequently, the market's stability may be jeopardized, affecting overall growth and competitiveness within the industry.

Market Trends of the Global Pharmaceutical Glycerine Market

The global pharmaceutical glycerine market is experiencing a notable shift towards the adoption of plant-based glycerine, driven by increasing consumer demand for sustainability and vegan-friendly alternatives. This market trend is characterized by a growing preference for ethically sourced, clean-label products that adhere to higher standards of transparency and environmental responsibility. As pharmaceutical companies respond to consumer pressures and regulatory requirements, the transition from traditional animal-derived sources to plant-derived glycerine is gaining momentum, particularly in regions like Europe and North America. This shift not only reflects changing consumer preferences but also signals a broader commitment to sustainable practices within the pharmaceutical industry.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Technology Assessment

Global Pharmaceutical Glycerine Market Size by Type & CAGR (2026-2033)

• Market Overview
• 99.7% Purity
• Above 99.7% Purity

Global Pharmaceutical Glycerine Market Size by Source & CAGR (2026-2033)

• Market Overview
• Animal
• Plant

Global Pharmaceutical Glycerine Market Size by Application & CAGR (2026-2033)

• Market Overview
• Oral Use
• External use

Global Pharmaceutical Glycerine Market Size & CAGR (2026-2033)

• North America (Type, Source, Application)
  • US
  • Canada
• Europe (Type, Source, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Source, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Source, Application)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Source, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• IOI Oleo GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Archer Daniels Midland Company (ADM) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KLK Oleo (Malaysia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oleon NV (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dow, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cargill, Incorporated (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emery Oleochemicals (Malaysia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• P&G Chemicals (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wilmar International Limited (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• The Chemical Company (TCC) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Godrej Industries Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Twin Rivers Technologies, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VVF LLC (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Avril Group (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GLACONCHEMIE GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Croda International Plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rajaram Solvents Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 3F Chimica SpA (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Solvay SA (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Peter Greven GmbH & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations